Intrinsiqs

Is ANI Pharmaceuticals, Inc. overvalued?

ANI Pharmaceuticals, Inc. (ANIP) looks undervalued — trading about 223% below its fair value.

Undervalued
Current price $71.44 Fair value $231.10
Price
$71.44
Fair value
$231.10
Current P/E
8.7
Normal P/E
28.1
Market cap
$1.64B
Dividend yield
0.0%
Return on equity
20.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ANIP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.